Why the study?
Is lymphocyte-to-monocyte ratio associated with slow coronary flow?
Is lymphocyte-to-monocyte ratio associated with slow coronary flow?
Lymphocyte-to-monocyte ratio is significantly lower in patients with slow coronary flow and correlates with other inflammatory markers, suggesting its potential as a biomarker for this condition.
LMR may support SCF identification as an accessible marker; leaves open its diagnostic or prognostic utility.
AIM: Recently, lymphocyte-to-monocyte ratio (LMR) has emerged as a new indirect marker of inflammation which is associated with adverse outcomes in oncology and cardiovascular diseases. The aim of the study was to evaluate the relationship between LMR and slow coronary flow (SCF). PATIENTS & METHODS: A total of 100 consecutive patients with SCF and 100 consecutive patients with normal coronary flow were enrolled in this study. RESULTS: LMR was significantly lower in patients with SCF than in patients with normal coronary flow (p < 0.001). Also, LMR was negatively correlated with neutrophil-to-lymphocyte ratio and CRP levels (p < 0.001 and p = 0.005). LMR was found to be significantly and independently associated with SCF (p = 0.033). CONCLUSION: LMR was negatively correlated with serum C-reactive protein and neutrophil-to-lymphocyte ratio levels.
No takes yet. Share an insight, caveat, or question.
Yayla et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: